Reviewed by PillSeek Editorial Team · Last updated
Atelvia
Risedronate sodium hemi-pentahydrate 30.1 mg;risedronate sodium monohydrate 4.9 mg;
About This Medication
This medication is a Yellow Oval 12 mm, Delayed release tablet with imprint "EC;35". It contains Risedronate sodium hemi-pentahydrate 30.1 mg;risedronate sodium monohydrate 4.9 mg; of Risedronate sodium hemi-pentahydrate[risedronic acid];risedronate sodium monohydrate[risedronic acid];. It is manufactured by Allergan, Inc.. For details please contact your physician.
Basic Information
- Imprint
- EC;35
- Color
- Yellow
- Shape
- Oval
- Size
- 12 mm
Drug Information
- Strength
- Risedronate sodium hemi-pentahydrate 30.1 mg;risedronate sodium monohydrate 4.9 mg;
- Dosage Form
- Delayed release tablet
- RxCUI
- 1020066
Ingredients
- Active Ingredients
- Risedronate sodium hemi-pentahydrate[risedronic acid];risedronate sodium monohydrate[risedronic acid];
- Inactive Ingredients
- Edetate disodium;ferric oxide yellow;magnesium stearate;methacrylic acid - ethyl acrylate copolymer (1:1) type a;polysorbate 80;cellulose, microcrystalline;silicon dioxide;sodium starch glycolate type a potato;stearic acid;talc;triethyl citrate;
Additional Information
- Manufacturer
- Allergan, Inc.
- Status (Rx/OTC)
- Rx
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.